Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interconnection between cardiovascular, renal and metabolic disorders: A narrative review with a focus on Japan
Takashi Kadowaki, Hiroshi Maegawa, Hirotaka Watada, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 12, pp. 2283-2296
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

The cardio-renal-metabolic connection: a review of the evidence
Marella Marassi, Gian Paolo Fadini
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 80
Cardiovascular-Kidney-Metabolic (CKM) syndrome: A state-of-the-art review
Sneha Annie Sebastian, Inderbir Padda, Gurpreet Johal
Current Problems in Cardiology (2023) Vol. 49, Iss. 2, pp. 102344-102344
Closed Access | Times Cited: 58
Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with Cardiovascular-Kidney-Metabolic syndrome stage 0–3: a nationwide prospective cohort study
Weipeng Li, Chaonan Shen, Weiya Kong, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 24
Correlation between atherogenic index of plasma and cardiovascular disease risk across Cardiovascular–kidney–metabolic syndrome stages 0–3: a nationwide prospective cohort study
Yaohua Hu, Liang Yu, Jian‐Dong Li, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Animal Models for Studying Developmental Origins of Cardiovascular–Kidney–Metabolic Syndrome
You‐Lin Tain, Ying-Jui Lin, Chien‐Ning Hsu
Biomedicines (2025) Vol. 13, Iss. 2, pp. 452-452
Open Access | Times Cited: 1
Melatonin Use during Pregnancy and Lactation Complicated by Oxidative Stress: Focus on Offspring’s Cardiovascular–Kidney–Metabolic Health in Animal Models
You‐Lin Tain, Chien‐Ning Hsu
Antioxidants (2024) Vol. 13, Iss. 2, pp. 226-226
Open Access | Times Cited: 7
Evolution of sodium-glucose co-transporter 2 inhibitors from a glucose-lowering drug to a pivotal therapeutic agent for cardio-renal-metabolic syndrome
Hiroki Akiyama, Akihiro Nishimura, Naru Morita, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 14
JCS 2023 Guideline on the Primary Prevention of Coronary Artery Disease
Akira Fujiyoshi, Shun Kohsaka, Jun Hata, et al.
Circulation Journal (2024) Vol. 88, Iss. 5, pp. 763-842
Open Access | Times Cited: 5
Epidemiological characteristics and risk factors for heart failure in Japanese patients with type 2 diabetes: A retrospective analysis of the J‐DREAMS database
Mitsuru Ohsugi, Daisuke Nitta, Yusuke Naito, et al.
Journal of Diabetes Investigation (2025)
Open Access
Effects of PARP1 inhibitor PJ-34 on TGFα, IL-6, and IL-1β levels in diabetic nephropathy
Jing Ke, Yanan Fan, Shaochun Zhang
The Journal of Immunology (2025)
Closed Access
Metabolic Associations between Cardiovascular Disease, Diabetes and Kidney Disease
佳欣 王
Advances in Clinical Medicine (2025) Vol. 15, Iss. 02, pp. 1417-1427
Closed Access
U-shaped relationship of estimated glucose disposal rate with cardiovascular disease risk in cardiovascular-kidney-metabolic syndrome stages 0–3: a population-based prospective study
Xiaomin Liang, Kai Lai, Xiaohong Li, et al.
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access
Associations between dietary inflammatory index and cardiovascular kidney metabolic syndrome: insights from NHANES 2005–2018
Tianyao Shi, Fang Mei, Bai Xiao, et al.
Research Square (Research Square) (2025)
Closed Access
Association of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in population with cardiovascular-kidney-metabolic syndrome stages 0–4: evidence from a large cohort study
Fan-Shun Guo, Jia‐Hao Dou, Junxiang Wang, et al.
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access
Insulin in the regulation of the renin-angiotensin system: a new perspective on the mechanism of insulin resistance and diabetic complications
Т. С. Замолодчикова, С. М. Толпыго, Alexander V. Kotov
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 4
Peripheral Arterial Disease and the Diabetic Foot Syndrome: Neuropathy Makes the Difference! A Narrative Review
G. Rümenapf, Nour Abilmona, Stephan Morbach, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 2141-2141
Open Access | Times Cited: 4
Understanding the Role of Sex Hormones in Cardiovascular Kidney Metabolic Syndrome: Toward Personalized Therapeutic Approaches
Mustafa Güldan, S. Ünlü, Sama Mahmoud Abdel‐Rahman, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 15, pp. 4354-4354
Open Access | Times Cited: 4
AGE-RAGE Axis and Cardiovascular Diseases: Pathophysiologic Mechanisms and Prospects for Clinical Applications
Bijian Wang, Tiangao Jiang, Y. Q. Qi, et al.
Cardiovascular Drugs and Therapy (2024)
Open Access | Times Cited: 4
Association of visceral fat obesity with structural change in abdominal organs: fully automated three-dimensional volumetric computed tomography measurement using deep learning
Haruka Kiyoyama, Masahiro Tanabe, Mayumi Higashi, et al.
Abdominal Radiology (2025)
Closed Access
Association between atherogenic index of plasma and new-onset stroke in a population with cardiovascular-kidney-metabolic syndrome stages 0–3: insights from CHARLS
Y. Liu, Wenlong Li, Hanwen Zhou, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access
GRP78 Contributes to the Beneficial Effects of SGLT2 Inhibitor on Proximal Tubular Cells in DKD
Atsuko Nakatsuka, Satoshi Yamaguchi, Jun Wada
Diabetes (2024) Vol. 73, Iss. 5, pp. 763-779
Open Access | Times Cited: 3
Remnant cholesterol is an independent risk factor for the incidence of chronic kidney disease in newly-diagnosed type 2 diabetes: A nationwide population-based study
Soo Yeon Jang, Minwoong Kang, Eyun Song, et al.
Diabetes Research and Clinical Practice (2024) Vol. 210, pp. 111639-111639
Closed Access | Times Cited: 3
Real-world effectiveness of imeglimin in patients with type 2 diabetes: A retrospective longitudinal study in Japan
Hisayuki Katsuyama, Mariko Hakoshima, Takahiro Heshiki, et al.
Diabetes Research and Clinical Practice (2024) Vol. 213, pp. 111752-111752
Open Access | Times Cited: 3
Stem cell-derived exosomal MicroRNAs: Potential therapies in diabetic kidney disease
Han Wang, Jiajia Wang, Tiejun Liu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114961-114961
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top